Drug Topics

JULY 13, 2023

The news comes almost 2 weeks after Cyltezo’s entrance into the US biosimilars market as the first commercially available and FDA-approved interchangeable adalimumab biosimilar.

FDA 98

FDA 98

STAT

MARCH 28, 2024

Our colleague Sarah Owermohle joins us to explain the Supreme Court case that could have dramatic effects on access to medication abortion — and the development of new medicines. We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast.

FDA 96

FDA 96

STAT

APRIL 5, 2024

Hired someone new and exciting? Share the news with us, and we’ll share it with others.   Send us your changes, and we’ll find a home for them. Promoted a rising star? Finally solved that hard-to-fill spot?   That’s right. Send Don’t be shy.

78

78

STAT

MARCH 29, 2024

Hired someone new and exciting? Share the news with us, and we’ll share it with others.   Send us your changes, and we’ll find a home for them. Promoted a rising star? Finally solved that hard-to-fill spot?   That’s right. Send Don’t be shy.

82

82

STAT

MARCH 15, 2024

Hired someone new and exciting? Share the news with us, and we’ll share it with others.   Send us your changes, and we’ll find a home for them.  Don’t Promoted a rising star? Finally solved that hard-to-fill spot?   That’s right. Send  Don’t be shy.

90

90

STAT

MARCH 14, 2024

Bioethicist Holly Fernandez Lynch joins us to discuss the case of Amylyx Pharmaceuticals’ treatment for ALS and what its failure means for drug development. We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast.

100

100

STAT

APRIL 12, 2024

Hired someone new and exciting? Share the news with us, and we’ll share it with others.   Send us your changes, and we’ll find a home for them. Promoted a rising star? Finally solved that hard-to-fill spot?   That’s right. Send Don’t be shy.

68

68

STAT

MARCH 8, 2024

Hired someone new and exciting? Share the news with us, and we’ll share it with others.   Send us your changes, and we’ll find a home for them. Promoted a rising star? Finally solved that hard-to-fill spot?   That’s right. Send Don’t be shy.

83

83

STAT

JANUARY 8, 2024

It’s the time of year when we’re most susceptible to such messaging: Surveys show that at least one-third of our New Year’s resolutions focus on exercising, losing weight, or eating better. The marketing campaigns work: Each January, fitness app downloads spike 36% higher than usual.

143

143

STAT

JANUARY 26, 2024

Hired someone new and exciting? Share the news with us, and we’ll share it with others.   Send us your changes, and we’ll find a home for them.  Don’t Promoted a rising star? Finally solved that hard-to-fill spot?   That’s right. Send  Don’t be shy.

93

93

STAT

JANUARY 5, 2024

Hired someone new and exciting? Share the news with us, and we’ll share it with others.  That’s  Send us your changes, and we’ll find a home for them.  Don’t Promoted a rising star? Finally solved that hard-to-fill spot?  That’s right. Send

91

91

STAT

FEBRUARY 9, 2024

Hired someone new and exciting? Share the news with us, and we’ll share it with others.   Send us your changes, and we’ll find a home for them.  Don’t Promoted a rising star? Finally solved that hard-to-fill spot?   That’s right. Send  Don’t be shy.

83

83

STAT

FEBRUARY 23, 2024

Hired someone new and exciting? Share the news with us, and we’ll share it with others.   Send us your changes, and we’ll find a home for them. Promoted a rising star? Finally solved that hard-to-fill spot?   That’s right. Send Don’t be shy.

78

78

OctariusRx

MARCH 25, 2024

You may hear about them on the evening news or get a notice from a drug company/distributor, or even see it posted on social media. If you’d like more details, or have a specific question about FDA drug recalls, reach out to us. Contact us for assistance. As we all know, recalls happen quite frequently.

FDA 75

FDA 75

STAT

DECEMBER 8, 2023

Hired someone new and exciting? Share the news with us, and we’ll share it with others.    Send us your changes, and we’ll find a home for them. Promoted a rising star? Finally solved that hard-to-fill spot?   That’s right. Send Don’t be shy.

93

93

STAT

FEBRUARY 2, 2024

Hired someone new and exciting? Share the news with us, and we’ll share it with others.   Send us your changes, and we’ll find a home for them.  Don’t Promoted a rising star? Finally solved that hard-to-fill spot?   That’s right. Send  Don’t be shy.

75

75

STAT

SEPTEMBER 14, 2023

Our colleague Helen Branswell joins us to discuss the state of the Covid-19 pandemic heading into the fall and the rollout of boosters shots aimed at the latest viral variants. We also discuss the latest news in the life sciences, including an IPO implosion, a debate at the FDA, and the ups and downs of a career in biotech.

FDA 116

FDA 116

STAT

APRIL 4, 2024

Oruka Therapeutics CEO Lawrence Klein joins us to discuss how his company raised its first round of financing before competing with major players in the inflammation space. We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast.

Vaccines 64

Vaccines 64

STAT

DECEMBER 1, 2023

Hired someone new and exciting? Share the news with us, and we’ll share it with others.     Send us your changes, and we’ll find a home for them. Promoted a rising star? Finally solved that hard-to-fill spot?   That’s right.  Don’t be shy.

86

86

STAT

NOVEMBER 2, 2023

Biotech consultant Frank David joins us to explain the wild world of subgroup analyses and how to discern science from spin. We also discuss the latest news in the life sciences, including the future of Sarepta and the retirement of a biotech stalwart. Read the rest…

FDA 94

FDA 94

STAT

OCTOBER 20, 2023

Hired someone new and exciting? Share the news with us, and we’ll share it with others.  That’s  Send us your changes, and we’ll find a home for them. Promoted a rising star? Finally solved that hard-to-fill spot?  That’s right. Send Don’t be shy.

96

96

STAT

FEBRUARY 16, 2024

Hired someone new and exciting? Share the news with us, and we’ll share it with others. That’s  Send us your changes, and we’ll find a home for them. Promoted a rising star? Finally solved that hard-to-fill spot?  That’s right. Send Don’t be shy.

67

67

STAT

JANUARY 12, 2024

Hired someone new and exciting? Share the news with us, and we’ll share it with others.  That’s  Send us your changes, and we’ll find a home for them.  Don’t Promoted a rising star? Finally solved that hard-to-fill spot?  That’s right. Send

75

75

STAT

MARCH 7, 2024

STAT’s Lev Facher joins us to explain his reporting on why virtually every sector of American society is standing in the way of their use. We also discuss the latest news in the life sciences, including the haves and have-nots of venture capital, and the race to develop effective oral treatments for obesity.

77

77

STAT

FEBRUARY 15, 2024

STAT Washington correspondent Rachel Cohrs joins us to explain the industry’s struggle to make headway — and how it factors into the 2024 election. The pharmaceutical industry, in court and in Congress, is working to water down legislation that will let Medicare negotiate certain drug prices.

84

84

STAT

OCTOBER 26, 2023

Our colleague Andrew Joseph joins us to explain the decades-old cancer-treating technology that had its star turn at this week’s big oncology conference in Europe. We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast.

95

95

European Pharmaceutical Review

APRIL 15, 2024

billion to expand the planned FUJIFILM Diosynth Biotechnologies manufacturing facility in Holly Springs, North Carolina, US. This news follows the organisation’s announcement of a $2 billion investment in the facility in March 2021. FUJIFILM Corporation is planning to invest $1.2 billion, FUJIFILM confirmed. The post Fujifilm plans $1.2

84

84

STAT

JANUARY 19, 2024

Hired someone new and exciting? Share the news with us, and we’ll share it with others.    Send us your changes, and we’ll find a home for them. Don’t Promoted a rising star? Finally solved that hard-to-fill spot?   That’s right. Send  Don’t be shy.

70

70

STAT

DECEMBER 15, 2023

Hired someone new and exciting? Share the news with us, and we’ll share it with others.  That’s  Send us your changes, and we’ll find a home for them.  Don’t Promoted a rising star? Finally solved that hard-to-fill spot?  That’s right. Send

77

77

STAT

OCTOBER 27, 2023

Hired someone new and exciting? Share the news with us, and we’ll share it with others.  That’s  Send us your changes, and we’ll find a home for them. Promoted a rising star? Finally solved that hard-to-fill spot?  That’s right. Send Don’t be shy.

85

85

STAT

SEPTEMBER 22, 2023

Hired someone new and exciting? Share the news with us, and we’ll share it with others.    Send us your changes, and we’ll find a home for them. Promoted a rising star? Finally solved that hard-to-fill spot?   That’s right. Send Don’t be shy.

89

89

STAT

JUNE 22, 2023

Our colleague Bob Herman joins us to explain his year-long investigation into some brazen conflicts of interest in the world of prescription drug pricing. Then, STAT’s Helen Branswell calls in to walk us through a news-packed week for vaccines, including weighty decisions for Covid-19 and RSV. Read the rest…

Vaccines 87

Vaccines 87

STAT

SEPTEMBER 15, 2023

Hired someone new and exciting? Share the news with us, and we’ll share it with others.  That’s  Send us your changes, and we’ll find a home for them.  Don’t Promoted a rising star? Finally solved that hard-to-fill spot?  That’s right. Send

92

92

STAT

NOVEMBER 3, 2023

Hired someone new and exciting? Share the news with us, and we’ll share it with others.  That’s  Send us your changes, and we’ll find a home for them. Promoted a rising star? Finally solved that hard-to-fill spot?  That’s right. Send Don’t be shy.

74

74

STAT

JULY 20, 2023

What can Homer teach us about biotech? Neil Kumar, CEO of BridgeBio, joins us to talk about how his small company came to develop what could be a big drug — and why classical Greek literature remains relevant. Has Big Science gotten too big? And what’s the future of treating Alzheimer’s disease?

81

81

STAT

SEPTEMBER 1, 2023

Hired someone new and exciting? Share the news with us, and we’ll share it with others. That’s  Send us your changes, and we’ll find a home for them. Promoted a rising star? Finally solved that hard-to-fill spot?  That’s right. Send Don’t be shy.

81

81

STAT

MARCH 1, 2024

Hired someone new and exciting? Share the news with us, and we’ll share it with others. That’s  Send us your changes, and we’ll find a home for them. Promoted a rising star? Finally solved that hard-to-fill spot?  That’s right. Send Don’t be shy.

80

80